Cargando…
CXCR4 Inhibition Ameliorates Severe Obliterative Pulmonary Hypertension and Accumulation of C-Kit(+) Cells in Rats
Successful curative treatment of severe pulmonary arterial hypertension with luminal obliteration will require a thorough understanding of the mechanism underlying the development and progression of pulmonary vascular lesions. But the cells that obliterate the pulmonary arterial lumen in severe pulm...
Autores principales: | Farkas, Daniela, Kraskauskas, Donatas, Drake, Jennifer I., Alhussaini, Aysar A., Kraskauskiene, Vita, Bogaard, Harm J., Cool, Carlyne D., Voelkel, Norbert F., Farkas, Laszlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933653/ https://www.ncbi.nlm.nih.gov/pubmed/24587052 http://dx.doi.org/10.1371/journal.pone.0089810 |
Ejemplares similares
-
Copper Deficiency Induced Emphysema Is Associated with Focal Adhesion Kinase Inactivation
por: Mizuno, Shiro, et al.
Publicado: (2012) -
Increased Eicosanoid Levels in the Sugen/Chronic Hypoxia Model of Severe Pulmonary Hypertension
por: Al-Husseini, Aysar, et al.
Publicado: (2015) -
Severe pulmonary hypertension: The role of metabolic and endocrine disorders
por: Bogaard, Harm J., et al.
Publicado: (2012) -
Fenretinide Causes Emphysema, Which Is Prevented by Sphingosine 1-Phoshate
por: Yasuo, Masanori, et al.
Publicado: (2013) -
Immunomodulatory strategies prevent the development of autoimmune emphysema
por: Hanaoka, Masayuki, et al.
Publicado: (2010)